All articles tagged: Postpartum depression (F53.0)


HealthDay 11 July at 03.53 PM Bothersome Urinary Symptoms Common 12 Months Postpartum Bothersome urinary symptoms and incontinence are common at 12 months postpartum, according to a study recently published in Urogynecology.Sonia Bhandari Randhawa, M.D., from University of Texas Southwestern Medical Center in Dallas, and colleagues sought to identify factors associated with persistent (i.e., 12 months postpartum), # Psychiatry # Internal Medicine # Urology # Family Practice 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 08 July at 03.20 PM Study Looks at Depression, Stress in Both Parents After Detection of Fetal Anomalies Prospective parents experience heightened levels of depression and traumatic stress after the detection of fetal anomalies leading to termination of pregnancy, according to a study published online June 20 in BJOG: An International Journal of Obstetrics and Gynaecology.Mona Bekkhus, Ph.D., from the University of Oslo in Norway, and colle # Psychiatry # OBGYN & Women's Health 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 03 July at 01.58 PM Perinatal Suicide Tied to Intimate Partner Problems, Depression, Substance Use Perinatal suicide is often associated with intimate partner problems (IPPs) and behavioral health issues, according to a study published online June 27 in JAMA Network Open.Kara Zivin, Ph.D., from Michigan Medicine in Ann Arbor, and colleagues used data from the National Violent Death Reporting System (2003 through 2021) to # Psychiatry # Family Practice # OBGYN & Women's Health 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 25 March at 05.43 AM A new $16,000 postpartum depression drug is here. How will insurers handle it? Zuranolone, a newly approved treatment for postpartum depression, offers promise for sufferers, but access remains uncertain due to lacking insurance coverage guidelines. While zuranolone presents a novel approach to treating depression by targeting hormone function, its high cost and insurance ambiguity pose barriers to widespread use. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 15 December at 08.35 PM Drug Maker Says Women Can Now Access Postpartum Depression Pill Zurzuvae (zuranolone), the first postpartum depression pill approved for use in the United States, is now available to women who need it. The medication, which is now stocked in specialty pharmacies, can also be shipped directly to patients, Biogen and Sage Therapeutics Inc. said in a news release Thursday."Having an option like Zurzuvae that ca # Psychiatry # Pharmacy # Family Practice # OBGYN & Women's Health 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 28 November at 10.58 PM Neighborhood Disadvantage Tied to Higher Postpartum Depression Risk Residing in more disadvantaged neighborhoods is associated with a greater risk for postpartum depression (PPD), according to a study published online Nov. 13 in JAMA Network Open.Ticara L. Onyewuenyi, M.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues examined whether neighborhood disadvantage is a # Psychiatry # Family Practice # OBGYN & Women's Health 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 08 November at 11.50 PM New Postpartum Depression Drug Comes With Hefty Price Tag A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients will not be able to afford the medication.Zurzuvae (zuranolone) was first <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depressi # Psychiatry # Pharmacy # Family Practice # OBGYN & Women's Health 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


Medpage Today 17 November at 10.31 PM Two Treatments That Don't Work for Osteoarthritis WASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 11 November at 07.56 AM Scoring System Could Mean Better Access to Lung Transplant Scoring system could improve access for hard-to-match candidates due to height and blood type. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 07 November at 07.50 AM How key results could influence health policy The results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 05 November at 07.00 PM Mpox Cases in Congo May Be Stabilizing GOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 02 November at 07.40 AM Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 31 October at 06.30 AM Report: Rethink Race-Based Adjustments in Clinical Tools The slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medpage Today 25 October at 02.09 PM Patients More Satisfied With AI's Answers Than Those From Their Doctor Patients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 25 October at 12.40 PM Surgical innovation: The intelligent turbine insufflator The Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 24 October at 07.50 AM Genetic variants in melatonin receptor linked to idiopathic osteoporosis Columbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 23 October at 10.58 PM Risk for Psychiatric Disorders Up for Offspring of Moms With Eating Disorder Offspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn